NKNancy Kim

Nancy Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nancy Kim has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Healthcare Resource Use and Costs of Allogeneic Hematopoietic Stem Cell Transplantation Complications: A Scoping Review

    by Nancy V. Kim, Gemma McErlean, Serena Yu, Ian Kerridge, Matthew Greenwood, Richard De Abreu Lourenco

    Allogeneic hematopoietic stem cell transplant (allo-HSCT) is an expensive and resource intensive procedure. This study aims to review the literature pertaining to healthcare resource utilization (HRU) and costs associated with allo-HSCT complications. The review followed the Joanna Briggs Institute methodology for scoping reviews. The PubMed, EMBASE, and Health Business Elite were searched in addition to the grey literature. Eligibility criteria included studies that reported HRU and/or costs associated with adult (≥18 years) allo-HSCT. Studies were categorized according to complications of allo-HSCT including graft-versus-host disease (acute and chronic GVHD) and infections (fungal, cytomegalovirus, virus-associated hemorrhagic cystitis, and acute respiratory tract infection). Commonly reported HRU and cost measures were extracted, including those associated with the direct management of allo-HSCT complications and intensive care unit (ICU) admissions. Reported costs were standardized to 2022 United States Dollars. Patients who experienced GVHD or infection post-transplant had an overall greater HRU including higher rates of hospitalization, hospital readmission, ICU admission, and longer length of stay compared to those patients who did not. Patients with severe or refractory GVHD and/or infection following allo-HSCT required greater healthcare intervention. This scoping review synthesizes the current literature on HRU and costs associated with post allo-HSCT complications. Patients who experienced post allo-HSCT complications had higher HRU and incurred higher costs overall, noting the variability across studies in their clinical context, reporting of HRU, and cost measures.


  • Open Access

    Healthcare Resource Utilization and Cost Associated with Allogeneic Hematopoietic Stem Cell Transplantation: A Scoping Review

    by Nancy V. Kim, Gemma McErlean, Serena Yu, Ian Kerridge, Matthew Greenwood, Richard De Abreu Lourenco


  • Open Access

    Spending more, doing more, or both? An alternative method for quantifying utilization during hospitalizations

    by Tara Lagu, Harlan M. Krumholz, Kumar Dharmarajan, Chohreh Partovian, Nancy Kim, Purav S. Mody, Shu‐Xia Li, Kelly M. Strait, Peter K. Lindenauer

    BACKGROUND: Because relative value unit (RVU)‐based costs vary across hospitals, it is difficult to use them to compare hospital utilization.OBJECTIVE: To compare estimates of hospital utilization using RVU‐based costs and standardized costs.DESIGN: Retrospective cohort.SETTING AND PATIENTS: Years 2009 to 2010 heart failure hospitalizations in a large, detailed hospital billing database that contains an itemized log of costs incurred during hospitalization.INTERVENTION: We assigned every item in the database with a standardized cost that was consistent for that item across all hospitals.MEASUREMENTS: Standardized costs of hospitalization versus RVU‐based costs of hospitalization.RESULTS: We identified 234 hospitals with 165,647 heart failure hospitalizations. We observed variation in the RVU‐based cost for a uniform “basket of goods” (10th percentile cost $1,552; 90th percentile cost of $3,967). The interquartile ratio (Q75/Q25) of the RVU‐based costs of a hospitalization was 1.35 but fell to 1.26 after costs were standardized, suggesting that the use of standardized costs can reduce the “noise” due to differences in overhead and other fixed costs. Forty‐six (20%) hospitals had reported costs of hospitalizations exceeding standardized costs (indicating that reported costs inflated apparent utilization); 42 hospitals (17%) had reported costs that were less than standardized costs (indicating that reported costs underestimated utilization).CONCLUSIONS: Standardized costs are a novel method for comparing utilization across hospitals and reduce variation observed with RVU‐based costs. They have the potential to help hospitals understand how they use resources compared to their peers and will facilitate research comparing the effectiveness of higher and lower utilization. Journal of Hospital Medicine 2013;8:373–379. © 2013 Society of Hospital Medicine


  • Streptococcal Orbital Abscesses

    by Sabah A. Shah, Dale R. Meyer, Edward Wladis, Jennifer A. Sivak-Callcott, Geva Mannor, Cat Burkat, Nancy Kim


  • Open Access

    Primary care physicians, office-based practice, and the meaning of quality improvement

    by Eric Holmboe, Nancy Kim, Sarah Cohen, Maureen Curry, Anne Elwell, Marcia K. Petrillo, Thomas P. Meehan